Ana Hidalgo‐Simon
Leiden University Medical Center(NL)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Biomedical Ethics and Regulation, CAR-T cell therapy research, Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Economics and Policy
Most-Cited Works
- → Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth(2020)186 cited
- → Evaluation of the effectiveness of risk minimization measures(2012)63 cited
- → Comparison Between Paediatric and Adult Suspected Adverse Drug Reactions Reported to the European Medicines Agency: Implications for Pharmacovigilance(2014)59 cited
- → Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review(2012)53 cited
- → Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice(2018)34 cited
- → Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance(2011)26 cited
- → Drug‐induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab(2015)21 cited
- → Drug-Induced PML: A Global Agenda for a Global Challenge(2012)16 cited
- → Environmental risk assessment of advanced therapies containing genetically modified organisms in the EU(2021)12 cited
- → Towards a better use of scientific advice for developers of advanced therapies(2020)11 cited